Chen et al., 2012 carried out a meta-analysis of small AMD pharmacogenetic studies and noted that CFH rs1061170 might be associated with treatment response of neovascular AMD to anti-VEGF agents (S62). This evidence concerns the gene VEGFA and age-related macular degeneration.